卫光生物
(002880)
| 流通市值：58.42亿 | | | 总市值：58.42亿 |
| 流通股本：2.27亿 | | | 总股本：2.27亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 221,871,720.94 | 1,266,661,537.66 | 790,899,107.6 | 518,095,318.12 |
| 营业收入 | 221,871,720.94 | 1,266,661,537.66 | 790,899,107.6 | 518,095,318.12 |
| 二、营业总成本 | 180,979,840.59 | 976,684,778.23 | 599,161,140.13 | 382,125,542.04 |
| 营业成本 | 138,141,105.22 | 768,051,323.71 | 454,996,009.81 | 293,635,521.83 |
| 税金及附加 | 2,381,997.03 | 10,901,244.6 | 7,152,529.83 | 4,738,271.48 |
| 销售费用 | 4,150,959.32 | 36,106,311.62 | 19,848,696.17 | 11,402,709.71 |
| 管理费用 | 20,945,094.47 | 95,014,067.84 | 66,951,615.46 | 41,363,357.21 |
| 研发费用 | 11,119,422.48 | 46,023,648.08 | 35,629,988.19 | 21,591,044.44 |
| 财务费用 | 4,241,262.07 | 20,588,182.38 | 14,582,300.67 | 9,394,637.37 |
| 其中:利息费用 | 4,294,295.34 | 21,674,813.77 | 15,042,855 | 9,965,736.16 |
| 其中:利息收入 | 138,006.14 | 1,261,719.08 | 1,053,231.16 | 1,073,373.77 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | - | 1,870,660.37 | - | - |
| 加:投资收益 | 1,510,482.05 | 3,773,426.16 | 3,152,675.52 | 2,022,539.02 |
| 信用减值损失(新) | -4,892,938.48 | -25,044,059.98 | -17,055,412.91 | -13,543,662.61 |
| 其他收益 | 1,817,943.12 | 13,435,128.48 | 6,953,068.26 | 4,175,464.99 |
| 四、营业利润 | 39,327,367.04 | 284,011,914.46 | 184,788,298.34 | 128,624,117.48 |
| 加:营业外收入 | 12,944.74 | 140,382.3 | 73,604.21 | 28,853.93 |
| 减:营业外支出 | 162,802.61 | 1,129,343.11 | 743,516.53 | 425,063.67 |
| 五、利润总额 | 39,177,509.17 | 283,022,953.65 | 184,118,386.02 | 128,227,907.74 |
| 减:所得税费用 | 8,407,548.69 | 37,231,859.29 | 26,300,467.72 | 20,652,808.89 |
| 六、净利润 | 30,769,960.48 | 245,791,094.36 | 157,817,918.3 | 107,575,098.85 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 30,769,960.48 | 245,791,094.36 | 157,817,918.3 | 107,575,098.85 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 30,982,974.04 | 246,320,739.85 | 157,860,537.25 | 107,646,345.47 |
| 少数股东损益 | -213,013.56 | -529,645.49 | -42,618.95 | -71,246.62 |
| 扣除非经常损益后的净利润 | 30,880,984.38 | 238,651,552.88 | 155,455,095.31 | 106,303,706.91 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.14 | 1.09 | 0.7 | 0.47 |
| (二)稀释每股收益 | 0.14 | 1.09 | 0.7 | 0.47 |
| 九、综合收益总额 | 30,769,960.48 | 245,791,094.36 | 157,817,918.3 | 107,575,098.85 |
| 归属于母公司股东的综合收益总额 | 30,982,974.04 | 246,320,739.85 | 157,860,537.25 | 107,646,345.47 |
| 归属于少数股东的综合收益总额 | -213,013.56 | -529,645.49 | -42,618.95 | -71,246.62 |
| 公告日期 | 2026-04-27 | 2026-04-27 | 2025-10-31 | 2025-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |